CD4 and neuroblastoma: On the other hand, it has to be considered that treatment with anti-CD25 mAb efficiently depleted CD4+CD25high Treg cells, in the syngeneic NB model, but a population of CD4+CD25−/lowFoxP3+ cells or other CD4+ Treg precursors were left untouched20.